Showing 23,141 - 23,160 results of 31,482 for search '"5', query time: 0.18s Refine Results
  1. 23141
  2. 23142
  3. 23143

    General practice database on mortality in adults on methylphenidate: cohort study by Bruno Stricker, Katia Verhamme, Kiki Cheung

    Published 2022-08-01
    “…We investigated whether methylphenidate in adults was associated with an increased risk of psychiatric events such as depression, and suicide attempt and overall mortality.Design A population-based matched cohort design.Setting The Integrated Primary Care Information system, a general practitioners (GP) database in the Netherlands with a source population of 2.5 million inhabitants.Participants During the study period between 1 June 1996 and 1 January 2018, 8905 adults started methylphenidate and were matched to 10 non-users on sex, age, GP practice and ad prescription date. …”
    Get full text
    Article
  4. 23144

    Association between microplastics and the functionalities of human gut microbiome by Bei Gao, Lixia Chen, Lizhi Wu, Shirui Zhang, Sunan Zhao, Zhe Mo, Zhijian Chen, Pengcheng Tu

    Published 2025-01-01
    “…In the present study, concentrations of microplastics in human blood were detected through pyrolysis-gas chromatography/mass spectrometry in 39 adults. Five types of microplastics were found in human blood, including polyvinyl chloride, polyethylene, polypropylene, polystyrene, and polyamide 66. …”
    Get full text
    Article
  5. 23145
  6. 23146

    Obesity as a risk factor for COVID-19 breakthrough infection among the fully vaccinated urban population of South Gujarat – A retrospective cohort study by Mayank Jha, Pratham Kholwadwala, Vatsal Kalariya, Mamta Rani, Jayant Patel, Hitesh Shah, Rushikesh Shukla

    Published 2025-01-01
    “…As high as 144 (17.6%) of respondents were having history of previous infection before vaccination, and around 42 (5.1%) respondents of the overall study population were infected after the first dose of vaccination. …”
    Get full text
    Article
  7. 23147
  8. 23148
  9. 23149
  10. 23150
  11. 23151
  12. 23152
  13. 23153
  14. 23154
  15. 23155
  16. 23156
  17. 23157
  18. 23158
  19. 23159
  20. 23160

    The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication by Christian Frois, Thomas O’Connell, Jacqueline Pesa, John Fastenau

    Published 2013-05-01
    “…In our analyses, the average difference in antipsychotic costs per capita between PDL and non-PDL states was less than $0.6M or 1.5% (p=0.95). The average difference in antipsychotic utilization per capita was less than 2.8% (p=0.91) and in branded antipsychotic market share was 0.7% (p=0.59). …”
    Get full text
    Article